Literature DB >> 8116948

Lack of residual lung damage in horses in which Rhodococcus equi-induced pneumonia had been diagnosed.

D M Ainsworth1, K A Beck, C E Boatwright, K A Snedden, W C Rebhun.   

Abstract

The effect of prior Rhodococcus equi-induced pneumonia on pulmonary health was investigated in 5 horses (< 24 months old) using endoscopy, radiography, hematologic and bronchoalveolar lavage analyses, and pulmonary function testing. Rhodococcus equi-induced pneumonia had been diagnosed in principal horses when they were foals. Diagnosis was based on positive results of transtracheal aspiration and thoracic radiography at the time of initial clinical examination. Results of reevaluation of the respiratory system of these horses (R+) were compared with those of 5 age-matched healthy horses (R-) that lacked clinical or historical evidence of foalhood pneumonia. Significant differences in variables between the 2 groups of horses were not evident. In both groups, most horses had radiographic evidence of an accentuated bronchointerstitial pattern, although results of analysis of bronchoalveolar lavage specimens were normal and mononuclear cells predominated. Variability in results of the pulmonary function tests was observed within the between the 2 groups of horses. Only normalized dynamic lung compliance was slightly lower in the previously infected horses, but this difference was not significant. We concluded that horses previously infected with and successfully treated for R equi-induced pneumonia do not have detectable evidence of residual lung damage.

Entities:  

Mesh:

Year:  1993        PMID: 8116948

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  2 in total

1.  Extra-pulmonary Rhodococcus equi in a thoroughbred foal.

Authors:  T S Nay
Journal:  Can Vet J       Date:  1996-10       Impact factor: 1.008

2.  Resistance studies of erythromycin and rifampin for Rhodococcus equi over a 10-year period.

Authors:  T Buckley; E McManamon; S Stanbridge
Journal:  Ir Vet J       Date:  2007-12-01       Impact factor: 2.146

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.